The global Encephalitis Treatment market was valued at USD 21.21 Billion in 2023 and growing at a CAGR of 5.36% from 2023 to 2033. The market is expected to reach USD 35.75 Billion by 2033. Encephalitis is swelling in the brain that happens due to viral infection. The arboviruses cause encephalitis, which insects can pass on to people and animals. Its treatment sector is growing significantly because of many breakthrough therapies. It is showing a bigger trend in the healthcare sector as innovative medical advancements are reshaping the scenario and offering big opportunities in the market. Encephalitis is an infection which can happen due to bacterial infection, viral infection, autoimmune inflammation, insect bites, etc. The key objective of encephalitis treatment is the reduction of swelling and avoidance of any further complications. The surge in the prevalence of encephalitis cases and growing programs and initiatives for the treatment of the conditions are some of the factors which are fueling the Encephalitis Treatment market.
There is an increase in the prevalence of encephalitis, and there is a growing awareness and development of new treatments of a less invasive nature. All these factors are fueling the growth of the market. There is also an advancement in diagnostics and investment in R&D activities, which is also propelling the market's growth. Moreover, there is a surge in the population along with growing international travelling and government initiatives, which are contributing to market growth. The awareness regarding encephalitis is growing; hence, more people are seeking diagnosis and treatment, increasing the demand for effective treatment and therapies. Diagnostics advancements have led to earlier and better detection with improved patient outcomes. Also, high mortality and morbidity rates related to encephalitis help in growing the encephalitis treatment. Government initiatives are also happening for the vaccination drives, which further help the market. As cases of encephalitis grow, it has become crucial for people to choose the vaccination measure, boosting the market. The increase in cancer cases is also helping expand market growth. It is generally because as the body fights cancer, some of the immune responses may trigger encephalitis, which eventually helps to grow the encephalitis treatment market. Also, the investment in the healthcare infrastructure has increased, along with an increase in the initiatives by public and private organizations for the conditions and the treatment options, an increase in the demand for effective treatments, and a surge in the spending on public health programs are offering a good opportunity for the market growth. Other factors, such as an increase in the geriatric population, changes in lifestyle, and an increase in disposable income, further expand this encephalitis treatment market. This treatment is considered crucial as, in some cases, encephalitis can be fatal, and hence prompt diagnosis and treatment are very crucial as it is tough to predict the effect of encephalitis on each individual, which eventually is driving the treatment market.
Get an overview of this study by requesting a free sample
Growing cases of encephalitis among children – Based on one of the articles of 2023, there were growing cases of influenza-related encephalitis in children in Kerala. There were growing incidences of encephalopathy (IAE) among young children all across Kerala, and it could become a serious concern. Also, based on another article, between 2008 and 2014, there were around 44,000 cases in India and around 6000 deaths due to encephalitis. In 2016, there were a growing number of cases of encephalitis, with more than 125 children dying in one district of India. Globally, the number of cases of encephalitis also increased by around 12.5%, i.e. from 1284,160 in 1990 to 1444,720 in 2019. These factors are eventually driving the Encephalitis Treatment market.
Shortage of skilled professionals – There is a need for more trained professionals who can properly treat Encephalitis. Also its treatment cost is high. All these factors are acting as restraints for the market. Moreover, there is a poor healthcare infrastructure in low-income countries, which is also acting as a hindrance to the Encephalitis Treatment market.
Surge in the cases of cancer – Based on one of the studies, around 10 million people died of cancer in 2019 worldwide. This figure was below 6 million in 1990. It shows that there was a significant increase in cancer death cases by around 75% between 1990 and 2019. Based on another article, in 2022, there were around 20 million new cases of cancer and around 9.7 million deaths because of cancer. The number of people who lived for at least five years after cancer diagnosis was 53.5 million globally. It has been observed that every 1 in 5 people is catching cancer in their lifetime. Also, every 1 in 9 men and 1 in 12 women die of cancer. It has been observed that as the body fights cancer diseases, some immune reactions trigger encephalitis, creating the demand for encephalitis treatment. All these factors eventually drive the Encephalitis Treatment market in the forecasting period.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global Encephalitis Treatment market, with a 37.55% share of the market revenue in 2023. It is attributed to the presence of key players in the region, which also has better healthcare infrastructure. Globally, encephalitis affects 10 to 15 people in every 100,000 people yearly. More than 250,000 patients in the US were diagnosed alone in the last ten years. The condition could affect anyone, but it is more prone to younger people. Hence, the encephalitis treatment has the highest market share in the region.
North America Region Encephalitis Treatment Market Share in 2023 - 37.55%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The treatment segment is divided into antiviral agents, steroid injections, antibiotics, immunoglobin therapy, plasmapheresis and others. The antibiotics segment dominated the market, with a market share of around 35.21% in 2023. Encephalitis, which is caused by Lyme disease, is generally cured with intravenous antibiotics, and it is generally ceftriaxone. There are also many supportive treatments, which include drugs for decreasing headaches, reducing fever, etc. Antibiotics and antifungal medicines are generally used when encephalitis is due to bacterial and fungal infection.
The end-user segment is divided into Clinics, Hospitals, & Others. The hospitals segment dominated the market, with a market share of around 52.31% in 2023. It is attributed to the fact that some people suffering from autoimmune encephalitis require long-term treatment with immunosuppressive medicines, which include mycophenolate mofetil, azathioprine, tocilizumab or rituximab. Autoimmune encephalitis due to tumours needs treatment of these tumours, which includes surgery, chemotherapy, radiation or a combination of treatments, which leads to a significant amount of money. Hence, hospitals hold the highest market share.
Report Description:
Attribute | Description |
---|---|
Market Size | Revenue (USD Billion) |
Market size value in 2023 | USD 21.21 Billion |
Market size value in 2033 | USD 35.75 Billion |
CAGR (2024 to 2033) | 5.36% |
Historical data | 2020-2022 |
Base Year | 2023 |
Forecast | 2024-2033 |
Region | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level. |
Segments | Treatment and End User |
North America region emerged as the largest market for the Encephalitis Treatment.
The market's growth will be influenced by growing cases of encephalitis among children.
Shortage of skilled professionals could hamper the market growth.
Surge in the cases of cancer will provide huge opportunities to the market.
Key players are F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Pfizer Inc., Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Allergan, Basilea Pharmaceutica Ltd., Sanofi and Melinta Therapeutics LLC among others.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Treatment
4.3.2. Market Attractiveness Analysis By End User
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Growing cases of encephalitis among children
5.3. Restraints
5.3.1. Shortage of skilled professionals
5.4. Opportunities
5.4.1. Surge in the cases of cancer
5.5. Challenges
5.5.1. Economic slowdown
6. Global Encephalitis Treatment Market Analysis and Forecast, By Treatment
6.1. Segment Overview
6.2. Antiviral Agents
6.3. Steroid Injections
6.4. Antibiotics
6.5. Immunoglobin Therapy
6.6. Plasmapheresis
6.7. Others
7. Global Encephalitis Treatment Market Analysis and Forecast, By End User
7.1. Segment Overview
7.2. Clinics
7.3. Hospitals
7.4. Others
8. Global Encephalitis Treatment Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Encephalitis Treatment Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Encephalitis Treatment Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. F. Hoffmann-La Roche Ltd.
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Merck & Co., Inc.
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Pfizer Inc.
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Abbott Laboratories
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. GlaxoSmithKline plc
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Teva Pharmaceutical Industries Ltd.
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Allergan
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Basilea Pharmaceutica Ltd.
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Sanofi
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Melinta Therapeutics LLC
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
List of Table
1. Global Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
2. Global Antiviral Agents, Encephalitis Treatment Market, By Region, 2020-2033 (USD Billion)
3. Global Steroid Injections, Encephalitis Treatment Market, By Region, 2020-2033 (USD Billion)
4. Global Antibiotics, Encephalitis Treatment Market, By Region, 2020-2033 (USD Billion)
5. Global Immunoglobin Therapy, Encephalitis Treatment Market, By Region, 2020-2033 (USD Billion)
6. Global Plasmapheresis, Encephalitis Treatment Market, By Region, 2020-2033 (USD Billion)
7. Global Others, Encephalitis Treatment Market, By Region, 2020-2033 (USD Billion)
8. Global Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
9. Global Clinics, Encephalitis Treatment Market, By Region, 2020-2033 (USD Billion)
10. Global Hospitals, Encephalitis Treatment Market, By Region, 2020-2033 (USD Billion)
11. Global Hospitals, Encephalitis Treatment Market, By Region, 2020-2033 (USD Billion)
12. Global Others, Encephalitis Treatment Market, By Region, 2020-2033 (USD Billion)
13. North America Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
14. North America Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
15. U.S. Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
16. U.S. Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
17. Canada Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
18. Canada Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
19. Mexico Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
20. Mexico Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
21. Europe Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
22. Europe Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
23. Germany Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
24. Germany Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
25. France Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
26. France Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
27. U.K. Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
28. U.K. Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
29. Italy Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
30. Italy Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
31. Spain Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
32. Spain Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
33. Asia Pacific Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
34. Asia Pacific Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
35. Japan Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
36. Japan Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
37. China Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
38. China Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
39. India Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
40. India Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
41. South America Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
42. South America Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
43. Brazil Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
44. Brazil Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
45. Middle East and Africa Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
46. Middle East and Africa Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
47. UAE Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
48. UAE Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
49. South Africa Encephalitis Treatment Market, By Treatment, 2020-2033 (USD Billion)
50. South Africa Encephalitis Treatment Market, By End User, 2020-2033 (USD Billion)
List of Figures
1. Global Encephalitis Treatment Market Segmentation
2. Global Encephalitis Treatment Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Encephalitis Treatment Market Attractiveness Analysis By Treatment
9. Global Encephalitis Treatment Market Attractiveness Analysis By End User
10. Global Encephalitis Treatment Market Attractiveness Analysis By Region
11. Global Encephalitis Treatment Market: Dynamics
12. Global Encephalitis Treatment Market Share By Treatment (2023 & 2033)
13. Global Encephalitis Treatment Market Share By End User (2023 & 2033)
14. Global Encephalitis Treatment Market Share By Regions (2023 & 2033)
15. Global Encephalitis Treatment Market Share By Company (2023)
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global Encephalitis Treatment market based on below mentioned segments:
Global Encephalitis Treatment Market by Treatment:
Global Encephalitis Treatment Market by End-user:
Global Encephalitis Treatment by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date